MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 133 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,617,000 | +37.7% | 412,189 | +81.5% | 0.36% | +41.3% |
| Q1 2016 | $1,900,000 | -49.8% | 227,051 | -48.9% | 0.25% | -49.3% |
| Q3 2015 | $3,783,000 | -53.9% | 444,550 | -33.1% | 0.50% | -56.4% |
| Q2 2015 | $8,214,000 | +28.1% | 664,298 | +23.1% | 1.15% | -2.3% |
| Q1 2015 | $6,411,000 | -6.6% | 539,626 | -11.1% | 1.18% | -14.5% |
| Q4 2014 | $6,862,000 | +84.8% | 607,288 | +43.6% | 1.38% | +62.9% |
| Q3 2014 | $3,714,000 | – | 422,975 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 514,853 | $2,595,000 | 2.23% |
| GARRISON BRADFORD & ASSOCIATES INC | 98,001 | $494,000 | 0.48% |
| Catalyst Capital Advisors LLC | 380,896 | $1,920,000 | 0.44% |
| Knoll Capital Management, LLC | 160,585 | $809,000 | 0.42% |
| Tekla Capital Management LLC | 757,050 | $3,816,000 | 0.38% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 524,800 | $2,645,000 | 0.13% |
| Integre Asset Management, LLC | 103,493 | $522,000 | 0.12% |
| CAMBRIDGE TRUST CO | 220,003 | $1,109,000 | 0.10% |
| JAMISON EATON & WOOD INC /NJ | 62,782 | $316,000 | 0.09% |
| STONERIDGE INVESTMENT PARTNERS LLC | 88,304 | $445,000 | 0.09% |